Adnkronos (Adnkronos) – "The guiding principle of the Consolidated Law on Pharmaceutical Legislation is access to medicines for citizens, the most vulnerable, the vulnerable, and those with multiple pathologies. We want to ensure safe access to medicines regardless of geographic origin, income, or culture." This was stated by Marcello Gemmato, Undersecretary of Health, speaking at the meeting "The Future of Pharmaceutical Legislation: A Systemic Vision," organized by Nuove Reti in Rome.
The event will focus on the Consolidated Law on Pharmaceutical Legislation: the governance of pharmaceutical expenditure, the integration of healthcare information systems, industrial competitiveness, the role of local pharmacies, and equitable access to therapies.
"We try to get citizens to adhere to treatment. This is an extraordinary boost to compliance and therapeutic adherence, which translates into better care and savings for the public National Health Service, because citizens who adhere better to treatment get sick less, thus saving the state coffers," he added.
"Along with this, we're also securing the important pharmaceutical supply chain. Over the past three years, it has become Europe's leading sector, far surpassing Germany, and has a turnover of €74 billion, €69,2 billion of which is exported. This is therefore also a significant contribution to our export balance."
“Then there is a geopolitical and strategic vision in the production of active pharmacological ingredients, currently 80% produced in China and India.
We must reclaim the great chemical-pharmaceutical tradition that characterized Italy in the 1980s, precisely because it has therapeutic, geopolitical, and strategic importance. All of this is encapsulated in the Consolidated Law on Pharmaceutical Legislation, reflecting the extraordinary reformism of the Meloni government, which, with five years of stability, has been a driving force for innovation and renewal,” he concluded.
saving
webinfo@adnkronos.com (Web Info)